A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

NCT02095119 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Uterine Cervical Cancer

Interventions

DRUG: Nimotuzumab
DRUG: Cisplatin
DRUG: Gemcitabine
PROCEDURE: CT Scan

Sponsor

National Institute of Cancerología